Max Peters
Papers
1
Total Citations
2
H-Index
1
About
Max Peters is a leading researcher in the field of interventional oncology, with a primary focus on advancing precision radiotherapy and brachytherapy for prostate cancer. His most notable contribution is the development and clinical validation of the ROBiNSon system—a pioneering robotic device for MR-guided high-dose-rate (HDR) brachytherapy needle implantation. In his landmark 2024 proof-of-concept study, Peters demonstrated the feasibility and spatial accuracy of this robotic platform for single intraprostatic target delivery, marking a significant step toward fully automated, image-guided focal therapy. This work bridges the gap between robotics and real-time magnetic resonance imaging, offering the potential to dramatically improve treatment precision while reducing procedural invasiveness. Although early in its citation history (2 citations), the study represents a foundational advance in a rapidly evolving field. Peters’ research sits at the intersection of medical physics, urologic oncology, and surgical robotics, and his contributions are shaping the next generation of minimally invasive cancer interventions. His work is particularly relevant for researchers and clinicians seeking to integrate automation and high-field MRI into routine brachytherapy workflows.
Research Focus
Key Achievements
Top Papers
- 1